162: Dr. Jill interviews Bob Miller on A Lesser Known Pathway for Mast Cell Activation (MCAS)

Channel Favorite Bob Miller returns to sit down with Dr. Jill Carnahan to delve into a lesser-known pathway for Mast Cell Activation Syndrome (MCAS) and the detrimental effects of excess Qu. As a leading expert in functional medicine, Dr. Carnahan invites Bob Miller, a renowned researcher, to shed light on this often misunderstood condition. During the interview, Bob Miller reveals the fascinating role of the aryl hydrocarbon pathway in MCAS and how it can significantly impact one's health when not properly regulated. He explains the connection between excess Qu, a chemical compound found in certain foods and environmental toxins, and its influence on mast cell activation. Key points MCAS is common underlying cause of chronic complex disease and related to toxic load and infectious burden in our increasingly toxic world Why Aryl hydrocarbon's are more important than you think! This path is simulated by polycyclic aromatic hydrocarbons, arachidonic acid, mycotoxins and high homocysteine and causes weight gain, fatty liver and hyperglycemia/pre-diabetes Polycyclic aromatic hydrocarbons and dioxins are triggers to environmental toxicity and trigger the Aryl hydrocarbon receptor leading to increase inflammation and mast cell activation